Login Register Cart 0
Generic placeholder image

Current Alzheimer Research

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Pharmacological Attributes of Fenugreek with Special Reference to Alzheimer’s Disease

Author(s): Himanshi Varshney and Yasir Hasan Siddique*

Volume 20, Issue 2, 2023

Published on: 12 June, 2023

Page: [71 - 79] Pages: 9

DOI: 10.2174/1567205020666230525154300

Price: $65

conference banner
Abstract

Background: An annual plant, Fenugreek (Trigonellafoenum-graecum L.) has well-known health care benefits in Ayurvedic and Chinese medicine. Its leaves and seeds have alkaloids, amino acids, caumarins, flavonoids, saponins, and other bioactive components. Various pharmacological properties such as antioxidants, hypoglycemic, and hypolipidemic have been attributed to fenugreek. Trigonelline, diosgenin, and 4- hydroxyisoleucine have shown neuroprotection against Alzheimer’s disease, and the extract have also been reported to act as an anti-depressant, anti-anxiety, and also regulate cognitive functions. This review highlights various studies carried out on animals as well as on humans for the protective effect against Alzheimer’s disease.

Methods: The data presented in this review is taken from popular search engines, viz, Google Scholar, PubMed, and Scopus. This review highlights the studies and clinical trials performed to show the protective effect of Fenugreek on neurodegenerative diseases with special reference to AD from 2005 to 2023.

Results: Fenugreek improves cognitive deficits by Nrf2-mediated antioxidative pathway and provides neuroprotection against amyloid-beta-induced mitochondria dysfunction. It enhances SOD and catalase activities and scavenges reactive oxygen species to protect the cellular organelle from oxidative stress. It normalizes the tubulin protein and improved axonal growth by regulating nerve growth factors. Fenugreek can also influence metabolism.

Discussion: Fenugreek significantly improves the pathological symptoms of neurodegenerative disease, especially AD and can be used as a therapeutic agent to control disease conditions as evidenced by the review of the literature.

« Previous Next »
[1]
Khalil, W.; Roshdy, H.; Kassem, S. The potential therapeutic role of Fenugreek saponin against Alzheimers disease: Evaluation of apoptotic and acetylcholinesterase inhibitory activities. J. Appl. Pharm. Sci., 2016, 6, 166-173.
[http://dx.doi.org/10.7324/JAPS.2016.60925]
[2]
Prema, A.; Justin Thenmozhi, A.; Manivasagam, T.; Mohamed Essa, M.; Guillemin, G.J. Fenugreek seed powder attenuated aluminum chloride-induced tau pathology, oxidative stress, and inflammation in a rat model of Alzheimer’s disease. J. Alzheimers Dis., 2017, 60(s1), S209-S220.
[http://dx.doi.org/10.3233/JAD-161103] [PMID: 28269780]
[3]
Farid, MM.; Yang, X.; Kuboyama, T.; Tohda, C. Trigonelline recovers memory function in Alzheimer’s disease model mice: Evidence of brain penetration and target molecule. Sci. Rep., 2020, 2(10), 16424.
[http://dx.doi.org/10.1038/s41598-020-73514-1]
[4]
Olaiya, C.O.; Soetan, K.O. A review of the health benefits of fenugreek (Trigonella foenum-graecum L.): Nutritional, Biochemical and pharmaceutical perspectives. Int. J. Adv. Social. Sci. Humanit, 2014, 3-12.
[5]
Gaddam, A.; Galla, C.; Thummisetti, S.; Marikanty, R.K.; Palanisamy, U.D.; Rao, P.V. Role of Fenugreek in the prevention of type 2 diabetes mellitus in prediabetes. J. Diabetes Metab. Disord., 2015, 14(1), 74.
[http://dx.doi.org/10.1186/s40200-015-0208-4] [PMID: 26436069]
[6]
Gaur, V.; Bodhankar, S.L.; Mohan, V.; Thakurdesai, P.A. Neurobehavioral assessment of hydroalcoholic extract of Trigonella foenum-graecum seeds in rodent models of Parkinson’s disease. Pharm. Biol., 2013, 51(5), 550-557.
[http://dx.doi.org/10.3109/13880209.2012.747547] [PMID: 23368940]
[7]
Baliga, M.S.; Palatty, P.L.; Adnan, M.; Naik, T.S.; Kamble, P.S.; George, T.; D’souza, J.J. Anti-diabetic effects of leaves of Trigonella foenum-graecum L. (Fenugreek): Leads from preclinical studies. Journal of Food Chemistry and Nanotechnology, 2017, 3(2), 67-71.
[http://dx.doi.org/10.17756/jfcn.2017-039]
[8]
Prema, A.; Thenmozhi, A.J.; Manivasagam, T.; Essa, M.M.; Akbar, M.D.; Akbar, M. Fenugreek seed powder nullified aluminium chloride induced memory loss, biochemical changes, Aβ burden and apoptosis via regulating Akt/GSK3β signaling pathway. PLoS One, 2016, 11(11), e0165955.
[http://dx.doi.org/10.1371/journal.pone.0165955] [PMID: 27893738]
[9]
Nathan, J.; Panjwani, S.; Mohan, V.; Joshi, V.; Thakurdesai, P.A. Efficacy and safety of standardized extract of Trigonella foenum-graecum L seeds as an adjuvant to L-Dopa in the management of patients with Parkinson’s disease. Phytother. Res., 2014, 28(2), 172-178.
[http://dx.doi.org/10.1002/ptr.4969] [PMID: 23512705]
[10]
Mirzaie, M.; Khalili, M.; Kiasalari, Z.; Roghani, M. Neuroprotective and antiapoptotic potential of trigonelline in a striatal 6-hydroxydopamine rat model of Parkinson’s disease. Neurophysiology, 2016, 48(3), 176-183.
[http://dx.doi.org/10.1007/s11062-016-9586-6]
[11]
Pujari, R.; Thakurdesai, P. Fenugreek in Management of Neurological and Psychological Disorders; Fenugreek, 2022, pp. 229-257.
[http://dx.doi.org/10.1201/9781003082767-20]
[12]
Zameer, S.; Najmi, A.K.; Vohora, D.; Akhtar, M. A review on therapeutic potentials of Trigonella foenum graecum (fenugreek) and its chemical constituents in neurological disorders: Complementary roles to its hypolipidemic, hypoglycemic, and antioxidant potential. Nutr. Neurosci., 2018, 21(8), 539-545.
[http://dx.doi.org/10.1080/1028415X.2017.1327200] [PMID: 28504078]
[13]
Zhou, J.; Chan, L.; Zhou, S. Trigonelline: A plant alkaloid with therapeutic potential for diabetes and central nervous system disease. Curr. Med. Chem., 2012, 19(21), 3523-3531.
[http://dx.doi.org/10.2174/092986712801323171] [PMID: 22680628]
[14]
Anjomshoa, M.; Boroujeni, S.N.; Bagheri, E.; Lorigooini, Z.; Amini-Khoei, H. Possible involvement of N-methyl-D-aspartate receptor (NMDA-R) in the antidepressant-like effect of trigonelline in male mice. Curr. Pharm. Des., 2020, 26(39), 5067-5071.
[http://dx.doi.org/10.2174/1381612826666200610181259] [PMID: 32520677]
[15]
Fahanik-Babaei, J.; Baluchnejadmojarad, T.; Nikbakht, F.; Roghani, M. Trigonelline ameliorates learning and memory and synaptic plasticity impairment in intrahippocampal amyloid beta (1-40) rat model of alzheimer’s disease. Acta Med. Iran., 2018, 625-634.
[16]
Farid, M.M.; Nagase, T.; Yang, X.; Nomoto, K.; Kuboyama, T.; Inada, Y.; Tohda, C. Effects of Trigonellafoenum-graecum seeds extract on Alzheimer’s disease transgenic model mouse and its potential active compound transferred to the brain. Japanese J Food Chem Safety., 2021, 28, 63-70.
[17]
Tohda, C.; Urano, T.; Umezaki, M.; Nemere, I.; Kuboyama, T. Diosgenin is an exogenous activator of 1,25D3-MARRS/Pdia3/ERp57 and improves Alzheimer’s disease pathologies in 5XFAD mice. Sci. Rep., 2012, 2(1), 535.
[http://dx.doi.org/10.1038/srep00535] [PMID: 22837815]
[18]
Li, B.; Xu, P.; Wu, S.; Jiang, Z.; Huang, Z.; Li, Q.; Chen, D. Diosgenin attenuates lipopolysaccharide-induced Parkinson’s disease by inhibiting the TLR/NF-κB pathway. J. Alzheimers Dis., 2018, 64(3), 943-955.
[http://dx.doi.org/10.3233/JAD-180330] [PMID: 29966203]
[19]
Chiu, C.S.; Chiu, Y.J.; Wu, L.Y.; Lu, T.C.; Huang, T.H.; Hsieh, M.T.; Lu, C.Y.; Peng, W.H. Diosgenin ameliorates cognition deficit and attenuates oxidative damage in senescent mice induced by D-galactose. Am. J. Chin. Med., 2011, 39(3), 551-563.
[http://dx.doi.org/10.1142/S0192415X11009020] [PMID: 21598421]
[20]
Cai, B.; Zhang, Y.; Wang, Z.; Xu, D.; Jia, Y.; Guan, Y.; Liao, A.; Liu, G.; Chun, C.; Li, J. Therapeutic potential of diosgenin and its major derivatives against neurological diseases: recent advances. Oxid. Med. Cell. Longev., 2020, 2020, 1-16.
[http://dx.doi.org/10.1155/2020/3153082] [PMID: 32215172]
[21]
Koh, E.K.; Yun, W.B.; Kim, J.E.; Song, S.H.; Sung, J.E.; Lee, H.A.; Seo, E.J.; Jee, S.W.; Bae, C.J.; Hwang, D.Y. Beneficial effect of diosgenin as a stimulator of NGF on the brain with neuronal damage induced by Aβ-42 accumulation and neurotoxicant injection. Lab. Anim. Res., 2016, 32(2), 105-115.
[http://dx.doi.org/10.5625/lar.2016.32.2.105] [PMID: 27382379]
[22]
Yang, X.; Tohda, C. Diosgenin restores Aβ-induced axonal degeneration by reducing the expression of heat shock cognate 70 (HSC70). Sci. Rep., 2018, 8(1), 11707.
[http://dx.doi.org/10.1038/s41598-018-30102-8] [PMID: 30076345]
[23]
Gaur, V.; Bodhankar, S.L.; Mohan, V.; Thakurdesai, P. Antidepressant-like effect of 4-hydroxyisoleucine from Trigonella foenum graecum L. seeds in mice. Biomed. Aging Pathol., 2012, 2(3), 121-125.
[http://dx.doi.org/10.1016/j.biomag.2012.07.002]
[24]
Syed, Q.A.; Rashid, Z.; Ahmad, M.H.; Shukat, R.; Ishaq, A.; Muhammad, N.; Rahman, H.U.U. Nutritional and therapeutic properties of fenugreek ( Trigonella foenum-graecum ): a review. Int. J. Food Prop., 2020, 23(1), 1777-1791.
[http://dx.doi.org/10.1080/10942912.2020.1825482]
[25]
Assad, T.; Khan, R.A.; Rajput, M.A. Effect of Trigonella foenum-graecum Linn. seeds methanol extract on learning and memory. Metab. Brain Dis., 2018, 33(4), 1275-1280.
[http://dx.doi.org/10.1007/s11011-018-0235-1] [PMID: 29681009]
[26]
Beg, T.; Jyoti, S.; Naz, F. Rahul, ; Ali, F.; Ali, S.K.; Reyad, A.M.; Siddique, Y.H. Protective effect of kaempferol on the transgenic Drosophila model of Alzheimer’s disease. CNS Neurol. Disord. Drug Targets, 2018, 17(6), 421-429.
[http://dx.doi.org/10.2174/1871527317666180508123050] [PMID: 29745345]
[27]
Ali, F. Rahul, ; Naz, F.; Jyoti, S.; Siddique, Y.H. Health functionality of apigenin: A review. Int. J. Food Prop., 2017, 20(6), 1197-1238.
[http://dx.doi.org/10.1080/10942912.2016.1207188]
[28]
Thillaivanan, S.; Samraj, K. Challenges, constraints and opportunities in herbal medicines-a review. Int. J. Herb. Med., 2014, 2, 21-24.
[29]
Sharma, P.; Manchanda, R.; Goswami, R.; Chawla, S. Biodiversity and therapeutic potential of medicinal plants. In: Environmental Concerns and Sustainable Development; Shukla, V.; Kumar, N., Eds.; 27-44.
[http://dx.doi.org/10.1007/978-981-13-6358-0_2]
[30]
Elkordy, AA.; Haj-Ahmad, RR.; Awaad, AS.; Zaki, RM. An overview on natural product drug formulations from conventional medicines to nanomedicines: Past, present and future. J. Drug. Del. Sci. Tech., 2021, 1(63), 102459.
[31]
Saklani, A.; Kutty, S. Plant-derived compounds in clinical trials. Drug Discov. Today, 2008, 13(3-4), 161-171.
[http://dx.doi.org/10.1016/j.drudis.2007.10.010] [PMID: 18275914]
[32]
Foroumandi, E.; Javan, R.; Moayed, L.; Fahimi, H.; Kheirabadi, F.; Neamatshahi, M.; Shogofteh, F.; Zarghi, A. The effects of fenugreek seed extract supplementation in patients with Alzheimer’s disease: A randomized, double‐blind, placebo‐controlled trial. Phytother. Res., 2023, 37(1), 285-294.
[http://dx.doi.org/10.1002/ptr.7612] [PMID: 36199177]
[33]
Fridlender, M.; Kapulnik, Y.; Koltai, H. Plant derived substances with anti-cancer activity: From folklore to practice. Front. Plant Sci., 2015, 6, 799.
[http://dx.doi.org/10.3389/fpls.2015.00799] [PMID: 26483815]
[34]
Rai, K.S.; Bhat, K.M. Therapeutic Efficacy of Fenugreek Extract or/and Choline with Docosahexaenoic Acid in Attenuating Learning and Memory Deficits in Ovariectomized Rats. J Krishna Institute Med Sci, 2018, 1, 7.
[35]
Chowdhury, A.A.; Gawali, N.B.; Munshi, R.; Juvekar, A.R. Trigonelline insulates against oxidative stress, proinflammatory cytokines and restores BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice. Metab. Brain Dis., 2018, 33(3), 681-691.
[http://dx.doi.org/10.1007/s11011-017-0147-5] [PMID: 29277879]
[36]
Chowdhury, A.A.; Gawali, N.B.; Bulani, V.D.; Kothavade, P.S.; Mestry, S.N.; Deshpande, P.S.; Juvekar, A.R. In vitro antiglycating effect and in vivo neuroprotective activity of Trigonelline in d -galactose induced cognitive impairment. Pharmacol. Rep., 2018, 70(2), 372-377.
[http://dx.doi.org/10.1016/j.pharep.2017.09.006] [PMID: 29477946]
[37]
Nasiri, L.; Zardooz, H.; Reineh, Z.K.; Roghani, M. The effect of fenugreek methanolic extract on learning and memory in experimental model of Alzheimer’s disease in rat. J. Basic Clin Pathophysiol, 2019, 7, 486.
[38]
Nikbakht, F.; Roghani, M.; Fahanik-Babaei, J.; Baluchnejadmojarad, T. Trigonelline protects hippocampus against intracerebral A?(1–40) as a model of Alzheimer’s disease in the rat: Insights into underlying mechanisms. Metab. Brain Dis., 2019, 1, 34.
[http://dx.doi.org/10.1007/s11011-018-0338-8]
[39]
Algridi, M.A.; Azab, A.E. Ameliorating effects of fenugreek seeds powder against hematotoxicity induced by aluminum chloride in male rabbits. J. Biotechnology and Bioprocessing., 2021, 2, 2766-314.
[40]
Zeng, W.Y.; Tan, L.; Han, C.; Zheng, Z.Y.; Wu, G.S.; Luo, H.R.; Li, S.L. Trigonelline extends the lifespan of C. Elegans and delays the progression of age-related diseases by activating AMPK, DAF-16, and HSF-1. Oxid. Med. Cell. Longev., 2021, 2021, 1-11.
[http://dx.doi.org/10.1155/2021/7656834] [PMID: 34616504]
[41]
Cheng, S.M.; Ho, Y.J.; Yu, S.H.; Liu, Y.F.; Lin, Y.Y.; Huang, C.Y.; Ou, H.C.; Huang, H.L.; Lee, S.D. Anti-apoptotic effects of diosgenin in D-galactose-induced aging brain. Am. J. Chin. Med., 2020, 48(2), 391-406.
[http://dx.doi.org/10.1142/S0192415X20500202] [PMID: 32138534]
[42]
Hussain, SM.; Almutairi, N.; Alrakaf, F.; Aljameli, M.; Alshammari, M.; Alnasser, S. Nootropic effect of fenugreek seed extract against scopolamine induced cognitive decline in experimental mice. Psychology, 2020.
[43]
Roghani, M.; Sanaeierad, A.; Reineh, Z.K.; Mahmoudi, N.; Kiasalari, Z.; Rahmani, T. Diosgenin attenuates cognitive impairment in streptozotocin-induced diabetic rats: Underlying mechanisms. Neuropsychobiology, 2021, 80(1), 25-35.
[PMID: 32526752]
[44]
Belaïd-Nouira, Y.; Bakhta, H.; Bouaziz, M.; Flehi-Slim, I.; Haouas, Z.; Ben Cheikh, H. Study of lipid profile and parieto-temporal lipid peroxidation in AlCl3 mediated neurotoxicity. modulatory effect of fenugreek seeds. Lipids Health Dis., 2012, 11(1), 16.
[http://dx.doi.org/10.1186/1476-511X-11-16] [PMID: 22280491]
[45]
Moghadam, F.H.; Vakili-Zarch, B.; Shafiee, M.; Mirjalili, A. Fenugreek seed extract treats peripheral neuropathy in pyridoxine induced neuropathic mice. EXCLI J., 2013, 12, 282-290.
[PMID: 26417231]
[46]
Ahmed, S.I.; Hayat, M.Q.; Zahid, S.; Tahir, M.; Mansoor, Q.; Ismail, M.; Keck, K.; Bates, R. Isolation and identification of flavonoids from anticancer and neuroprotective extracts of <i>Trigonella foenum</i> graecum. Trop. J. Pharm. Res., 2017, 16(6), 1391-1398.
[http://dx.doi.org/10.4314/tjpr.v16i6.25]
[47]
Yousef nasab, F.; Hajinezhad, M.R.; Hashemi, H.; Miri, A. Comparison the effects of Trigonella foenum-graecum L. Seed and Cordia myxa fruit extracts on diabetes induced memory impairment in rats. International Journal of Basic Science in Medicine, 2017, 2(4), 184-188.
[http://dx.doi.org/10.15171/ijbsm.2017.34]
[48]
Khalili, M.; Alavi, M.; Esmaeil-Jamaat, E.; Baluchnejadmojarad, T.; Roghani, M. Trigonelline mitigates lipopolysaccharide-induced learning and memory impairment in the rat due to its anti-oxidative and anti-inflammatory effect. Int. Immunopharmacol., 2018, 61(61), 355-362.
[http://dx.doi.org/10.1016/j.intimp.2018.06.019] [PMID: 29935483]
[49]
Bafadam, S.; Beheshti, F.; Khodabakhshi, T.; Asghari, A.; Ebrahimi, B.; Sadeghnia, H.R.; Mahmoudabady, M.; Niazmand, S.; Hosseini, M. Trigonella foenum-graceum seed (Fenugreek) hydroalcoholic extract improved the oxidative stress status in a rat model of diabetes-induced memory impairment. Horm. Mol. Biol. Clin. Investig., 2019, 39(2), 20180074.
[http://dx.doi.org/10.1515/hmbci-2018-0074] [PMID: 31188777]
[50]
Varshney, V.; Garabadu, D. Ang(1–7) exerts Nrf2-mediated neuroprotection against amyloid beta-induced cognitive deficits in rodents. Mol. Biol. Rep., 2021, 48(5), 4319-4331.
[http://dx.doi.org/10.1007/s11033-021-06447-1] [PMID: 34075536]
[51]
Som, S.; Antony, J.; Dhanabal, S.P.; Ponnusankar, S. Neuroprotective role of Diosgenin, a NGF stimulator, against Aβ (1–42) induced neurotoxicity in animal model of Alzheimer’s disease. Metab. Brain Dis., 2022, 37(2), 359-372.
[http://dx.doi.org/10.1007/s11011-021-00880-8] [PMID: 35023028]
[52]
Tohda, C.; Lee, Y.A.; Goto, Y.; Nemere, I. Diosgenin-induced cognitive enhancement in normal mice is mediated by 1,25D3-MARRS. Sci. Rep., 2013, 3(1), 3395.
[http://dx.doi.org/10.1038/srep03395] [PMID: 24292207]
[53]
Fernandes, F; Barroso, MF De Simone, A Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease. J. Ethnopharmacol., 2022, 23(290), 115107.2022.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy